Joint; Nutrition; Collagen hydrolysate; Pain; Randomized controlled study
Abstract :
[en] Objective: Evaluation of the efficacy and safety of a food supplement made of collagen
hydrolysate 1200 mg/day versus placebo during 6 months, in subjects with joint pain at the
lower or upper limbs or at the lumbar spine.
Design: Comparative double-blind randomized multicenter study in parallel groups.
Setting: 200 patients of both genders of at least 50 years old with joint pain assessed as
≥30 mm
on a visual analogical scale (VAS).
Intervention: Collagen hydrolysate 1200 mg/day or placebo during 6 months.
Main outcome measure: Comparison of the percentage of clinical responder between the active
collagen hydrolysate group and the placebo group after 6 months of study. A responder subject
was defined as a subject experiencing a clinically significant improvement (i.e. by 20% or more)
in the most painful joint using the VAS score. All analyses were performed using an intent-totreat
procedure.
Results: At 6 months, the proportion of clinical responders to the treatment, according to
VAS scores, was significantly higher in the collagen hydrolysate (CH) group 51.6%, compared
to the placebo group 36.5% (p < 0.05). However, there was no significant difference between
groups at 3 months (44.1% vs. 39.6%, p = 0.53). No significant difference in terms of security
and tolerability was observed between the two groups.
Conclusions: This study suggests that collagen hydrolysate 1200 mg/day could increase the number
of clinical responders (i.e. improvement of at least 20% on the VAS) compared to placebo.
More studies are needed to confirm the clinical interest of this food supplement.
Disciplines :
Public health, health care sciences & services General & internal medicine
Author, co-author :
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Zegels, Brigitte ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Leonori, Lorenzo; Centre Hospitalier Universitaire de Liège - CHU > BRULL
Rabenda, Véronique ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Janssen, A.
Bourges, C.
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Effect of collagen hydrolysate in articular pain: A 6-month randomized, double-blind, placebo controlled study
Birrell F.N. Patterns of joint pain: lessons from epidemiology. Rheumatology (Oxford) 2004, 43(April (4)):408-409.
Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16(February (2)):137-162.
Schaffer D., Florin T., Eagle C., Marschner I., Singh G., Grobler M., et al. Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review. Med J Aust 2006, 185(November (9)):501-506.
Singh G., Wu O., Langhorne P., Madhok R. Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther 2006, 8(5):R153.
Lee F.H., Raja S.N. Complementary and alternative medicine in chronic pain. Pain 2011, 152(January (1)):28-30.
Santaguida P.L., Gross A., Busse J., Gagnier J., Walker K., Bhandari M., et al. Complementary and alternative medicine in back pain utilization report. Evid Rep Technol Assess (Full Rep) 2009, 177(January):1-221.
Henrotin Y., Lambert C., Couchourel D., Ripoll C., Chiotelli E., Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Osteoarthritis Cartilage 2011, 19(January (1)):1-21.
Lequesne M.G. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997, 24(April (4)):779-781.
Lequesne M.G., Mery C., Samson M., Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests. Scand J Rheumatol Suppl 1987, 65:85-89.
Hudak P.L., Amadio P.C., Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected] The Upper Extremity Collaborative Group (UECG). Am J Ind Med 1996, 29(June (6)):602-608.
Roland M., Morris R. A study of the natural history of back pain Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976) 1983, 8(March (2)):141-144.
Lauridsen H.H., Hartvigsen J., Manniche C., Korsholm L., Grunnet-Nilsson N. Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients. BMC Musculoskelet Disord 2006, 7:82.
Beaton D.E., Katz J.N., Fossel A.H., Wright J.G., Tarasuk V., Bombardier C. Measuring the whole or the parts? Validity, reliability, and responsiveness of the disabilities of the arm, shoulder and hand outcome measure in different regions of the upper extremity. J Hand Ther 2001, 14(April-June (2)):128-146.
EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16(December (3)):199-208. The EuroQol Group.
Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30(June (6)):473-483.
Clark K.L., Sebastianelli W., Flechsenhar K.R., Aukermann D.F., Meza F., Millard R.L., et al. 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin 2008, 24(May (5)):1485-1496.
Moskowitz R.W. Role of collagen hydrolysate in bone and joint disease. Semin Arthritis Rheum 2000, 30(October (2)):87-99.
Horvath G., Koroknai G., Acs B., Than P., Bellyei A., Illes T. Prevalence of radiographic primary hip and knee osteoarthritis in a representative Central European population. Int Orthop 2010, June.
Elder S.H., Borazjani A. Effect of collagen hydrolysate on chondrocyte-seeded agarose constructs. Biomed Mater Eng 2009, 19(6):409-414.
Ng K.W., Saliman J.D., Lin E.Y., Statman L.Y., Kugler L.E., Lo S.B., et al. Culture duration modulates collagen hydrolysate-induced tissue remodeling in chondrocyte-seeded agarose hydrogels. Ann Biomed Eng 2007, 35(November (11)):1914-1923.
Bello A.E., Oesser S. Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Curr Med Res Opin 2006, 22(November (11)):2221-2232.
Oesser S., Seifert J. Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen. Cell Tissue Res 2003, 311(March (3)):393-399.